Description: Article describes enhanced primary care models and provides citations on whether or not health care savings have been achieved.

Description: Table from an article in The Actuary Magazine on an analysis of risk management terminology: your guide to speaking ERM with different industries. Volume 4, Issue 6

Description: Health Watch, Issue 79, December 2015, Health Watch

Description: In this paper, we shine a light on the global public health epidemic of intimate partner violence (IPV). This first paper presents background information on the problem with a focus on health and economic impacts for the actuarial audience

Description: Risk adjustment is used to adjust the revenue stream to health insurers that sell ACA eligible plans and Medicare Advantage plans. This article compares and contrasts these risk adjustment programs.

Description: This report is a brief summary of a symposium held in Sweden in March 1972, initiated and sponsored by the Swedish insurance companies which discusses the side effects of the development of modern chemical industry and the exposure of living organisms to a variety of chemicals in the environment. The danger of the long term effects on health are addressed.

Description: This article is a review of another article that is an exposition of the mathematical methods used in the Framingham Study.

Description: Table from an article in The Actuary Magazine on an analysis of risk management terminology: your guide to speaking ERM with different industries. Volumn 4, Issue 6

Description: Social determinants of health (SDoH) have been a topic of growing interest in recent years, yet consensus about what the phrase represents and how health-related social needs should be studied or addressed by employers, health plans, providers and other stakeholders in the business of health care have been lacking. For many, low-income populations come to mind when considering the topic, yet SDoH include a wide range of factors beyond income. Many types of data are available, yet each presents distinct challenges and opportunities for analysis. In this article, we describe some of the underlying context for considering SDoH, as well as some of the potential data sources to consult and challenges to grapple with on this important topic.

Description: Introduction to additional actuarial research into development of and regulatory impact, economic impact and consumer impact of prescription drugs in the United States. Intended to further educate actuaries and others who work in this area and motivate more actuarial involvement to increase transparency, increase competition, better align stakeholder incentives and better mitigate total cost of care increases